Biography
Dr. Carter is a biophysicist with 20 years of experience in the biotechnology industry developing diagnostics, therapeutics and vaccines. He has founded five biotech companies including Proteinchemist.com, Compliment Corp, and PAI Life Sciences Inc. He is on the board of two Seattle biotechnology companies and acts as a scientific advisor for vaccine and global health institutes as well as having two affiliate professorships at the University of Washington in the School of Medicine and in Global Health. Darrick’s current research includes immune stimulants and vaccine formulations, structure-based protein design and immune oncology. He is inventor on over 160 patents and patent applications and has authored over 60 publications. Darrick received his Ph.D. from Oregon Health and Science University and his B.S. from Oregon State University.
Research Interest
immunomodulatory agents and formulations, vaccines and therapeutic
Biography
Thomas Bosch studied biology at the University of Munich, Germany, and Swansea, United Kingdom and earned his doctorate in 1986. Since 2000, Bosch has been a professor of general zoology at Kiel University. From 2010 to 2013, he served as vice president of Kiel University. Since 2013 Thomas Bosch is heading the interdisciplinary research center “Kiel Life Science†(KLS). Bosch is also coordinator of a new DFG-funded Collaborative Research Center on “Origin and Function of Metaorganismsâ€. The Center explores the multi-organismic interactions in plants, animals and humans. Bosch is the recipient of numerous awards including an honorary doctorate degree from St. Petersburg State University, Russia.
Research Interest
Multi-organismic interactions in plants, animals and humans.
Biography
Professor Bernhagen studied Biochemistry and Immunology at the University of Tübingen, Germany, and at Queen Mary College, London, UK. He performed a sandwich PhD thesis at the University of Tübingen and at the Picower Institute for Medical Research, Manhasset, NY, USA, and was trained as a postdoc at the Picower. Professor Bernhagen currently is a Full Professor of Biochemistry and Molecular Cell Biology at RWTH Aachen University, Germany, and is the Chair and Director of the homonymous institute. His main research interest has been on cytokines, chemokines and their role in inflammation, with a focus on MIF and the biochemical and structural features and mechanisms of such inflammatory mediators. He also studies the COP9 signalosome. Studied disease models encompass rodent model of atherosclerosis, sepsis, liver and kidney disease as well as colitis and colorectal cancer. Professor Bernhagen has authored more than 120 peer-reviewed papers in these areas, several of them published in leading journals such as Nature, Nature Medicine, or PNAS. He has serves on the editorial board of several journals and serves on several review committees for extramural funding and various fellowship organizations.
Research Interest
Inflammation